Google
MDWD — MEDIWOUND LTD (Healthcare >> Biotechnology)
MDWD FAQ
What is MDWD's ROE?
MEDIWOUND LTD reports a Return on Equity (ROE) of -63.02%.
What is MDWD's dividend yield?
MEDIWOUND LTD offers a dividend yield of 0.00%.
What is MDWD's Deepscope Quality Score?
Deepscope rates MDWD's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MDWD?
Deepscope's AI Timing Score for MDWD is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MDWD belong to?
MEDIWOUND LTD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 14.18
Price
-0.27
(-1.87%)
Day Change
|
|
|---|
MDWD, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 14.18 |
| PBV / Sector |
4.43 / 4.63
|
| Earning Per Share | -2.02 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
1.58 M
GREAT
|
| Average 1W Daily Value |
1.67 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
54% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:03 |
| Symbol | MDWD |
| Name | MEDIWOUND LTD |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 12.85 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 183.53 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 42 Hayarkon Street, Yavne, Israel, 8122745
Phone: 972 7 797 14100
Website: https://www.mediwound.com
Employees: 121
Sector: Healthcare >> Biotechnology
Description: MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
